← Back to Search

Community Health Navigator Program for Chronic Conditions (ENCOMPASS Trial)

N/A
Waitlist Available
Led By Kerry A McBrien, MD, MPH
Research Sponsored by University of Calgary
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Stage 3b or greater chronic kidney disease (estimated glomerular filtration rate < 45 mL/min/1.73m2 in past year)
Established ischemic heart disease (at least one instance of a physician billing diagnosis with a relevant International Classification of Diseases, 9th Edition [ICD-9] code recorded in electronic medical record (EMR), or known to health care team)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 36 months
Awards & highlights

ENCOMPASS Trial Summary

This trial is testing a community health navigator program to see if it can help patients with multiple long-term health conditions get the care and resources they need.

Who is the study for?
This trial is for individuals with multiple long-term health conditions like severe high blood pressure, heart failure, ischemic heart disease, advanced kidney disease (stage 3b or greater), COPD or asthma with frequent visits, and poorly controlled diabetes. Participants must be able to consent and not live in a long-term care facility.Check my eligibility
What is being tested?
The ENCOMPASS study tests a Community Health Navigator Program where trained community members help patients navigate the healthcare system. It aims to improve access to services for those with complex health conditions in Alberta.See study design
What are the potential side effects?
Since this intervention involves guidance rather than medication, typical drug side effects are not expected. However, there may be indirect effects related to changes in healthcare utilization.

ENCOMPASS Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My kidney function is reduced, with a filtration rate below 45 mL/min.
Select...
I have been diagnosed with heart disease.
Select...
I have COPD or asthma and have seen a doctor for it at least twice last year.
Select...
I have been diagnosed with congestive heart failure.
Select...
My diabetes has been poorly controlled, with an A1C over 9% in the past year.

ENCOMPASS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 36 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 36 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acute care service use
Secondary outcome measures
Acute care costs
All-cause mortality
Anxiety symptoms
+21 more

ENCOMPASS Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Community health navigator program for six months.
Group II: ControlActive Control1 Intervention
Usual health care.

Find a Location

Who is running the clinical trial?

University of CalgaryLead Sponsor
780 Previous Clinical Trials
841,551 Total Patients Enrolled
11 Trials studying Coronary Artery Disease
10,613 Patients Enrolled for Coronary Artery Disease
Kerry A McBrien, MD, MPHPrincipal InvestigatorUniversity of Calgary
3 Previous Clinical Trials
333 Total Patients Enrolled
3 Trials studying Coronary Artery Disease
333 Patients Enrolled for Coronary Artery Disease

Media Library

Community Health Navigator Program Clinical Trial Eligibility Overview. Trial Name: NCT04790617 — N/A
Coronary Artery Disease Research Study Groups: Intervention, Control
Coronary Artery Disease Clinical Trial 2023: Community Health Navigator Program Highlights & Side Effects. Trial Name: NCT04790617 — N/A
Community Health Navigator Program 2023 Treatment Timeline for Medical Study. Trial Name: NCT04790617 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are being selected for this clinical investigation?

"Affirmative, according to clinicaltrials.gov this research is actively looking for volunteers. It was first posted on March 10th 2021 and the last update was November 1st 2022. 400 participants need to be enrolled between a single site."

Answered by AI

Are there any remaining vacancies for this research initiative?

"Correct. Evidence found on clinicaltrials.gov reveals that, since its inception in March 2021, this medical study is actively seeking enrolments from 400 patients across a single site. It was last modified on the 1st of November 2022."

Answered by AI
Recent research and studies
~10 spots leftby Jun 2024